The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study to evaluate surufatinib in patients with osteosarcoma and soft tissue sarcoma that has failed standard chemotherapy: Updated analysis.
 
Xing Zhang
No Relationships to Disclose
 
Qiuzhong Pan
No Relationships to Disclose
 
Bushu Xu
No Relationships to Disclose
 
Qiyan Cai
No Relationships to Disclose
 
Ruiqing Peng
No Relationships to Disclose
 
Lihong Zhang
No Relationships to Disclose
 
Hui Li
No Relationships to Disclose
 
Shiying Yu
No Relationships to Disclose